These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 12690904)

  • 1. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
    Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
    Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon.
    Lekakis J; Mavrikakis M; Papamichael C; Papazoglou S; Economou O; Scotiniotis I; Stamatelopoulos K; Vemmos C; Stamatelopoulos S; Moulopoulos S
    Am Heart J; 1998 Nov; 136(5):905-12. PubMed ID: 9812087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis.
    Lekakis J; Papamichael C; Mavrikakis M; Voutsas A; Stamatelopoulos S
    Am J Cardiol; 1998 Dec; 82(12):1555-7, A8. PubMed ID: 9874070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon.
    Ringqvist A; Jonason T; Leppert J; Ringqvist I
    Clin Sci (Lond); 1998 Mar; 94(3):239-43. PubMed ID: 9616257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of ascorbic acid attenuates endothelial dysfunction after short-term cigarette smoking.
    Stamatelopoulos KS; Lekakis JP; Papamichael CM; Papaioannou TG; Cimboneriou A; Stamatelopoulos SF
    Int J Vitam Nutr Res; 2003 Nov; 73(6):417-22. PubMed ID: 14743545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C.
    Hamabe A; Takase B; Uehata A; Kurita A; Ohsuzu F; Tamai S
    Am J Cardiol; 2001 May; 87(10):1154-9. PubMed ID: 11356389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal.
    Plotnick GD; Corretti MC; Vogel RA
    JAMA; 1997 Nov; 278(20):1682-6. PubMed ID: 9388088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of maternal endothelial dysfunction with preeclampsia.
    Chambers JC; Fusi L; Malik IS; Haskard DO; De Swiet M; Kooner JS
    JAMA; 2001 Mar; 285(12):1607-12. PubMed ID: 11268269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.
    Black CM; Halkier-Sørensen L; Belch JJ; Ullman S; Madhok R; Smit AJ; Banga JD; Watson HR
    Br J Rheumatol; 1998 Sep; 37(9):952-60. PubMed ID: 9783759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-arginine therapy in Raynaud's phenomenon?
    Agostoni A; Marasini B; Biondi ML; Bassani C; Cazzaniga A; Bottasso B; Cugno M
    Int J Clin Lab Res; 1991; 21(2):202-3. PubMed ID: 1815764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of acute oral antioxidants on diving-induced alterations in human cardiovascular function.
    Obad A; Palada I; Valic Z; Ivancev V; Baković D; Wisløff U; Brubakk AO; Dujić Z
    J Physiol; 2007 Feb; 578(Pt 3):859-70. PubMed ID: 17110413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation.
    Khan F; Belch JJ
    J Rheumatol; 1999 Nov; 26(11):2389-94. PubMed ID: 10555898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of seasonal variation in flow-mediated dilatation of the brachial artery in women with primary Raynaud's phenomenon and healthy controls.
    Klein-Weigel P; Krall K; Falkensammer J; Heinz-Erian P; Ulmer H; Fraedrich G
    Vasa; 2003 May; 32(2):69-73. PubMed ID: 12945098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C.
    Deng YB; Li TL; Xiang HJ; Chang Q; Li CL
    Pediatr Infect Dis J; 2003 Jan; 22(1):34-9. PubMed ID: 12544406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.